PHAC 4001 Lecture Notes - Lecture 21: Insulin Glargine, Nph Insulin, Gliflozin
12 May 2021
School
Department
Course
Professor
Document Summary
Phac 4001 lecture 21 march 8, 2021 therapeutic approaches to diabetes ii. Therapeutic lifestyle changes for diabetes: can be useful for addressing primary causes (ex. Increased physical activity: 2-1/2 hours of moderate intensity or 1-1/4 hours of high intensity exercise per week, diet modification, overall reduction in caloric intake, especially fats and refined carbohydrates. Increased intake of fruits, vegetables, whole grains and dietary fibre: weight reduction, gradual loss (5-10% of body mass per year) is generally preferred. Ideally bmi < 24. 9: all degrees of weight loss are beneficial. In severe cases, bariatric surgery (reduces stomach size) or pharmacological agent (orlistat; reduces fat absorption but no well tolerated to adverse effects) may be prescribed. Insulin and insulin analogues: regular insulin, insulin ispro, nph insulin, insulin glargine. Insulin secretagogues: glyburide (sulfonylurea), rapaglinide (meglitinide: metformin, gliflozins: dapagliflozin, canagliflozin (sglt2 inhibitors, thiazolidinediones: avandia (rosiglitazone), actos (pioglitazone) Incretin agents: sitagliptin (dppiv inhibitor), exenatide (incretin mimetic)
